<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01274104</url>
  </required_header>
  <id_info>
    <org_study_id>ARI-1350-Myalgia</org_study_id>
    <nct_id>NCT01274104</nct_id>
  </id_info>
  <brief_title>A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia</brief_title>
  <official_title>A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avera McKennan Hospital &amp; University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Avera McKennan Hospital &amp; University Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the effect vitamin D has in alleviating muscle pain
      or aches that may be caused by taking certain medications for treating high cholesterol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participation in this study will consist of at least two study visits, expected to occur over
      a period of up to four weeks. Study-related medication will be provided at no cost to
      participants. Participants will receive either Vitamin D or placebo (sugar pill).
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    PI resigned.
  </why_stopped>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brief Pain Inventory value</measure>
    <time_frame>14 days</time_frame>
    <description>Decrease in the level of muscle pain, based on values of Brief Pain Inventory short forms completed at the initial clinic visit and approximately four weeks later at the final clinic visit</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Hyperlipidemia</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will take 5,000 IU-capsules of vitamin D3 three times a day (for a total of 15,000 IU) for 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will take 3 capsules of placebo every day for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>15,000 IU of Vitamin D3 every day for 14 days</description>
    <arm_group_label>Vitamin D</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women who are between the ages of 18 and 88 years old

          -  A muscle symptom defined as any of the following: Myalgia (muscle aches with normal
             CK); Myopathy (muscle aches with increased CK up to 5 times above the upper limit of
             normal); or Myopathy for the purpose of further evaluation (muscle aches with
             increased CK up to 5 times the upper limit of normal)

        Exclusion Criteria:

          -  Women who are pregnant, breastfeeding or planning to become pregnant

          -  Morbidly obese with a BMI &gt;40 kg/m2

          -  Travel to southern states, areas near the Equator, etc., or use of artificial tanning
             beds, such that study participants have increased sunlight/UV rays exposure in the
             past 30 days or at any point during the trial

          -  Currently (within the last 2 weeks) using any of the following supplements: Vitamin
             D-3 (Cholecalciferol) of more than 400 IU orally daily, which would not exclude
             typical multi-vitamin use; Vitamin D-2 (Ergocalciferol); Calcitriol; or Coenzyme Q10

          -  Documented to be hyperglycemic or laboratory results show hyperglycemia prior to
             randomization

          -  Renal dysfunction defined as glomerular filtration rate less than 60 mL/min.

          -  Documented to have parathyroid abnormalities or parathyroid hormone laboratory results
             show the study participant is outside of the normal limits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wael Eid, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Avera McKennan Hospital &amp; University Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Avera Research Institute</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2011</study_first_submitted>
  <study_first_submitted_qc>January 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2011</study_first_posted>
  <last_update_submitted>April 21, 2015</last_update_submitted>
  <last_update_submitted_qc>April 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <name_title>Wael Eid, MD</name_title>
    <organization>Avera McKennan Hospital &amp; University Health Center</organization>
  </responsible_party>
  <keyword>statin-related myalgia</keyword>
  <keyword>high cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
    <mesh_term>Myalgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

